EXOR N.V. announced today the following Corporate Calendar for 2024:

• 10 April 2024: Board of Directors Meeting for the approval of the Company’s 2023 Annual Report

• 28 May 2024: Annual General Meeting of Shareholders for the adoption of the Company’s 2023 Financial Statements

• 25 September 2024: Board of Directors Meeting for the approval of the Company’s 2024 Half-Year Financial Report

Exor will hold its 2023 Investor Day event today in Turin, Italy. The event will be hosted by Exor’s CEO John Elkann, together with the Company’s leadership team. Attendance in person is by invitation only.

EXOR N.V. (AMS: EXO) (“Exor) starts today the process of the implementation of the Board resolution to cancel 13,008,289 ordinary shares or 5.6% of Exor's ordinary issued share capital.

These ordinary shares have been acquired as part of the Tender Offer completed on 12 October 2023 (for a total of 8,873,452 ordinary shares) and the share buyback program announced in 2022 (for a total of 4,134,837 ordinary shares).

Exor announces that S&P Global Ratings (S&P) communicated today that it has upgraded Exor’s long-term corporate credit rating to A- from BBB+, keeping a “stable” outlook.

The short-term rating of Exor is A-2.

Exor N.V. (“Exor” or the “Company”) announces the results of the Tender Offer set out in the Offer Memorandum published by the Company on 13 September 2023 (the “Offer Memorandum”). The Tender Offer closed at 17:40 CET on 12 October 2023.

On 10 October 2023, the reported closing price of the Ordinary Shares on Euronext Amsterdam was EUR 84.20 per Ordinary Share.

EXOR DELIVERS 23% GROWTH IN NAV PER SHARE IN H1,
OUTPERFORMING MSCI BY 11 p.p.

€1 BILLION BUYBACK PROGRAM ANNOUNCED
WITH TENDER OFFER AT UP TO 10% PREMIUM

• Exor reports NAV of €34.2 billion at 30 June 2023. NAV per share increased 22.8% over the first half of 2023, while outperforming the MSCI World Index by 11.3 p.p., mainly driven by the market performance of Listed Companies.